158 related articles for article (PubMed ID: 36645410)
1. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Lauer RC; Barry M; Smith TL; Thomas AM; Wu J; Du R; Lee JH; Rao A; Dobroff AS; Arap MA; Nunes DN; Silva IT; Dias-Neto E; Chen I; McCance DJ; Cavenee WK; Pasqualini R; Arap W
Elife; 2023 Jan; 12():. PubMed ID: 36645410
[TBL] [Abstract][Full Text] [Related]
2. PRUNE2 is a human prostate cancer suppressor regulated by the intronic long noncoding RNA PCA3.
Salameh A; Lee AK; Cardó-Vila M; Nunes DN; Efstathiou E; Staquicini FI; Dobroff AS; Marchiò S; Navone NM; Hosoya H; Lauer RC; Wen S; Salmeron CC; Hoang A; Newsham I; Lima LA; Carraro DM; Oliviero S; Kolonin MG; Sidman RL; Do KA; Troncoso P; Logothetis CJ; Brentani RR; Calin GA; Cavenee WK; Dias-Neto E; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8403-8. PubMed ID: 26080435
[TBL] [Abstract][Full Text] [Related]
3. miR-19a and miR-421 target PCA3 long non-coding RNA and restore PRUNE2 tumor suppressor activity in prostate cancer.
Bozgeyik E; Kocahan S; Temiz E; Bagis H
Mol Biol Rep; 2022 Jul; 49(7):6803-6815. PubMed ID: 34839449
[TBL] [Abstract][Full Text] [Related]
4. [Expression of PRUNE2 mRNA and its positive correlation with non-coding RNA PCA3 in leiomyosarcoma].
Yang JL; Cogdell D; Eddy J; Trent J; Price N; Zhang W
Zhonghua Zhong Liu Za Zhi; 2012 Jul; 34(7):497-500. PubMed ID: 22967466
[TBL] [Abstract][Full Text] [Related]
5. RNA biomarkers associated with metastatic progression in prostate cancer: a multi-institutional high-throughput analysis of SChLAP1.
Prensner JR; Zhao S; Erho N; Schipper M; Iyer MK; Dhanasekaran SM; Magi-Galluzzi C; Mehra R; Sahu A; Siddiqui J; Davicioni E; Den RB; Dicker AP; Karnes RJ; Wei JT; Klein EA; Jenkins RB; Chinnaiyan AM; Feng FY
Lancet Oncol; 2014 Dec; 15(13):1469-1480. PubMed ID: 25456366
[TBL] [Abstract][Full Text] [Related]
6. Prostate Cancer Antigen 3 Score Does Not Predict for Adverse Pathologic Features at Radical Prostatectomy or for Progression-free Survival in Clinically Localized, Intermediate- and High-risk Prostate Cancer.
Hegde JV; Veruttipong D; Said JW; Reiter RE; Steinberg ML; King CR; Kishan AU
Urology; 2017 Sep; 107():171-177. PubMed ID: 28552819
[TBL] [Abstract][Full Text] [Related]
7. Differential expression of PCA3 and its overlapping PRUNE2 transcript in prostate cancer.
Salagierski M; Verhaegh GW; Jannink SA; Smit FP; Hessels D; Schalken JA
Prostate; 2010 Jan; 70(1):70-8. PubMed ID: 19760627
[TBL] [Abstract][Full Text] [Related]
8. Biopsy and radical prostatectomy pathological patterns influence Prostate cancer gene 3 (PCA3) score.
De Luca S; Passera R; Bollito E; Milillo A; Scarpa RM; Papotti M; Coda R; Randone DF
Anticancer Res; 2013 Oct; 33(10):4657-62. PubMed ID: 24123045
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA PCA3 regulates prostate cancer through sponging miR-218-5p and modulating high mobility group box 1.
Zhang G; He X; Ren C; Lin J; Wang Q
J Cell Physiol; 2019 Aug; 234(8):13097-13109. PubMed ID: 30569456
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of tissue PCA3 expression in prostate cancer by RNA in situ hybridization--a correlative study with urine PCA3 and TMPRSS2-ERG.
Warrick JI; Tomlins SA; Carskadon SL; Young AM; Siddiqui J; Wei JT; Chinnaiyan AM; Kunju LP; Palanisamy N
Mod Pathol; 2014 Apr; 27(4):609-20. PubMed ID: 24072184
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA PCA3 gene promoter region is related to the risk of prostate cancer on Chinese males.
Zhou W; Tao Z; Wang Z; Hu W; Shen M; Zhou L; Wen Z; Yu Z; Wu X; Huang K; Hu Y; Lin X
Exp Mol Pathol; 2014 Dec; 97(3):550-3. PubMed ID: 25445501
[TBL] [Abstract][Full Text] [Related]
12. The role of long non-coding RNA PCA3 in epithelial ovarian carcinoma tumorigenesis and progression.
Liu Y; Zong ZH; Guan X; Wang LL; Zhao Y
Gene; 2017 Oct; 633():42-47. PubMed ID: 28864116
[TBL] [Abstract][Full Text] [Related]
13. New targets for therapy in prostate cancer: differential display code 3 (DD3(PCA3)), a highly prostate cancer-specific gene.
Schalken JA; Hessels D; Verhaegh G
Urology; 2003 Nov; 62(5 Suppl 1):34-43. PubMed ID: 14607216
[TBL] [Abstract][Full Text] [Related]
14. New genomic structure for prostate cancer specific gene PCA3 within BMCC1: implications for prostate cancer detection and progression.
Clarke RA; Zhao Z; Guo AY; Roper K; Teng L; Fang ZM; Samaratunga H; Lavin MF; Gardiner RA
PLoS One; 2009; 4(3):e4995. PubMed ID: 19319183
[TBL] [Abstract][Full Text] [Related]
15. Two-stage classifiers that minimize PCA3 and the PSA proteolytic activity testing in the prediction of prostate cancer recurrence after radical prostatectomy.
Jeske DR; Linehan JA; Wilson TG; Kawachi MH; Wittig K; Lamparska K; Amparo C; Mejia R; Lai F; Georganopoulou D; Smith SS
Can J Urol; 2017 Dec; 24(6):9089-9097. PubMed ID: 29260633
[TBL] [Abstract][Full Text] [Related]
16. Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates.
Väänänen RM; Ochoa NT; Boström PJ; Taimen P; Pettersson K
BMC Urol; 2015 Aug; 15():88. PubMed ID: 26294063
[TBL] [Abstract][Full Text] [Related]
17. Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.
Väänänen RM; Lilja H; Cronin A; Kauko L; Rissanen M; Kauko O; Kekki H; Vidbäck S; Nurmi M; Alanen K; Pettersson K
Clin Biochem; 2013 May; 46(7-8):670-4. PubMed ID: 23391636
[TBL] [Abstract][Full Text] [Related]
18. Early prediction of clinical response to checkpoint inhibitor therapy in human solid tumors through mathematical modeling.
Butner JD; Martin GV; Wang Z; Corradetti B; Ferrari M; Esnaola N; Chung C; Hong DS; Welsh JW; Hasegawa N; Mittendorf EA; Curley SA; Chen SH; Pan PY; Libutti SK; Ganesan S; Sidman RL; Pasqualini R; Arap W; Koay EJ; Cristini V
Elife; 2021 Nov; 10():. PubMed ID: 34749885
[TBL] [Abstract][Full Text] [Related]
19. The relationship between Prostate CAncer gene 3 (PCA3) and prostate cancer significance.
van Poppel H; Haese A; Graefen M; de la Taille A; Irani J; de Reijke T; Remzi M; Marberger M
BJU Int; 2012 Feb; 109(3):360-6. PubMed ID: 21883822
[TBL] [Abstract][Full Text] [Related]
20. PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells.
Lemos AE; Ferreira LB; Batoreu NM; de Freitas PP; Bonamino MH; Gimba ER
Tumour Biol; 2016 Aug; 37(8):11339-48. PubMed ID: 26960690
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
